Income Taxes - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Contingency [Line Items]
Net operating loss carryforward	$ 17,824	$ 2,115
NOL not subject to expiration	15,500
NOL subject to expiration	2,300
R&D tax credit carryforward	19,100	16,554
R&D credits not subject to expiration	2,500
R&D credits subject to expiration	23,600
Valuation allowance	(23,054)	(21,600)	$ (26,368)	$ (16,168)
Increase (decrease) in valuation allowance	1,500	(4,800)
Change in valuation allowance recorded to tax expense	900	4,800
Additions (reversals) to other accounts	2,357	(1)	(45)
Deferred tax liability not recognized, amount of unrecognized deferred tax liability, undistributed earnings of foreign subsidiaries	1,100
Liability for unrecognized tax benefits	32,700
Increase in unrecognized tax benefits is reasonably possible	9,000
Income tax examination, interest expense	1,200	300	$ 100
Unrecognized tax benefits, accrued interest	1,800	$ 600
State And Local Jurisdiction (Net Of Benefit)
Income Tax Contingency [Line Items]
R&D tax credit carryforward	$ 26,100